FORM OF ORDINARY SHARE PURCHASE WARRANT Procaps Group, S.A.Ordinary Share Purchase Warrant • December 3rd, 2024 • Procaps Group, S.A. • Pharmaceutical preparations
Contract Type FiledDecember 3rd, 2024 Company IndustryTHIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Hoche Partners Pharma Holding S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 58, rue Charles Martel, L-2134 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B206416, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance of this Warrant (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the tenth (10th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Procaps Group, S.A., a public limited liability company (société anonyme) incorporat
AGREEMENT DATED November 29, 2024 PROCAPS GROUP S.A “Pledgor” and HOCHE PARTNERS PHARMA HOLDING S.A. “Pledgee” and CRYNSSEN PHARMA GROUP LTD “Company” Share Pledge AgreementShare Pledge Agreement • December 3rd, 2024 • Procaps Group, S.A. • Pharmaceutical preparations
Contract Type FiledDecember 3rd, 2024 Company Industry
PROCAPS GROUP, S.A. SECURED CONVERTIBLE NOTE SUBSCRIPTION AGREEMENTSecured Convertible Note Subscription Agreement • December 3rd, 2024 • Procaps Group, S.A. • Pharmaceutical preparations • New York
Contract Type FiledDecember 3rd, 2024 Company Industry JurisdictionThis Secured Convertible Note Subscription Agreement (this “Agreement”) is made as of November 29, 2024 by and between Procaps Group, S.A., a public limited liability company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its registered office at 9 rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies’ Register (Registre de Commerce et des Sociétés, Luxembourg) under number B253360 (the “Company”) and Hoche Partners Pharma Holding S.A., a public limited liability company (société anonyme) governed by the laws of the Grand Duchy of Luxembourg with its registered office at 58, rue Charles Martel, L-2134 Luxembourg, Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B206416 (the “Subscriber”).